Aligos Therapeutics
Price & Volume
Stats
See more52W Range | $3.76-$46.80 |
Market Cap | $44.5M |
Shares Short | 391,884 |
Financials
See moreRevenue (12 Mos) | $3.2M |
Revenue Growth (YoY) | -68.5% |
Gross Profit (12 Mos) | -$65.1M |
Diluted EPS | -$17.47 |
News
See moreYahoo Finance • 4 days ago
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025
Yahoo Finance • 23 days ago
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
Yahoo Finance • 4 months ago
Aligos Therapeutics Presents Positive Data at APASL 2025
About
CEO | Dr. Lawrence M. Blatt MBA, Ph.D. |
CFO | Ms. Lesley Ann Calhoun CPA |
Address | One Corporate Drive, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
